what is depression. how treatment of depression with the help of mushroom is possible.

Depression is one of the most common types of mental disorder and often develops alongside anxiety.

Depression can be mild and short-lived or severe and long-lasting. Some people are affected by depression only once, while others may experience it more than once.

Depression can lead to suicide, but this can be prevented if appropriate support is provided. It is important to know that there is a lot that can be done to help young people who are thinking about suicide.

What causes depression?

Depression can occur as a reaction to something like someone speaking bad words, violence at school, the death of a loved one, or family problems such as domestic violence or family breakdown. Someone can become depressed after a long period of stress. It can also run in the family. Sometimes we may not know why it happens.

The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest study of its type ever conducted. Research has found the compound to be effective against difficult-to-treat depression, and larger trials are now underway. LONDON - The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest study of its kind ever conducted. Psilocybin was administered to 233 patients who had already tried at least two antidepressants in the past with little success, suggesting that the compound could have enormous benefits for those suffering from intractable depression. After receiving psilocybin, the patients entered a state of "dream walking" for four to six hours and then left the clinic after returning to their normal state. The study found that a 25 mg dose of psilocybin, given along with psychological support, triggered a reduction in depression levels three weeks after treatment. The study, published Thursday in the New England Journal of Medicine, was conducted internationally by the London-based COMPASS Pathways. Around 100 million people worldwide suffer from treatment-resistant depression, so the study's findings are a step in the right direction, says James Rocker, a consultant psychiatrist and senior clinical lecturer at King's College London, who was involved in the study. "Our task now is to investigate psilocybin for the treatment of resistant depression in larger studies with more participants, comparing it to both placebo and established treatment," Rocker said, according to a King's College London press release. The drugs were tested at doses of 1 mg, 10 mg, and 25 mg, and side effects reported in all groups included headache, nausea, and suicidal thoughts. However, according to Ravi Days, associate professor at the University College London Institute of Mental Health, there were no equal numbers of "severely depressed" participants in each dose group, which "doesn't appear to be in the paper," as reported by Reuters. Critics also expressed concern that this could lead to an increase in the use of magic mushrooms in non-pharmaceutical settings. A new study has found that psilocybin, a psychedelic chemical found in so-called magic mushrooms, may help treat depression in some patients. Researchers say a single dose of 25 mg of synthetic formulation psilocybin significantly reduced patients' depression scores - but was associated with unwanted side effects. For a peer-reviewed study published in the New England Journal of Medicine, researchers randomly assigned adults with treatment-resistant depression to a single dose of psilocybin. Patients with treatment-resistant depression had previously tried several different drugs to treat depression, but none of them worked, said Dr. Steve Levine, CB With News. Levine is senior vice president of patient access and medical affairs at mental health care company Compass Pathways, where he works closely with the study's lead author, Dr. By Guy Goodwin.